Joshua M Maher

5PUBLICATIONS
10CO-AUTHORS
Infectious agentsMedical bacteriologyMedical infection agents (incl. prions)Clinical microbiologyInfant and child health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 20, 2026
Evaluation of cefiderocol trailing and other unclear susceptibility testing endpoints for Acinetobacter spp.

|May 14, 2025
Aztreonam-avibactam Demonstrates Potent Activity Against Carbapenem-resistant Enterobacterales Collected From US Medical Centers Over a 6-year Period (2017-2022).

Krisztina M Papp-Wallace, Helio S Sader, Joshua M Maher

|Feb 05, 2025
Characterization of sulopenem antimicrobial activity using in vitro time-kill kinetics, synergy, post-antibiotic effect, and sub-inhibitory MIC effect methods against Escherichia coli and Klebsiella pneumoniae isolates.

Joshua M Maher, Michael D Huband, Jill M Lindley

|Oct 10, 2024
In vitro activity assessment of cefiderocol against Enterobacterales, Pseudomonas aeruginosa, and Acinetobacter spp., including β-lactam nonsusceptible molecularly characterized isolates, collected from 2020 to 2021 in the United States and European hospitals.

John H Kimbrough, Joshua M Maher, Helio S Sader

|Feb 02, 2023
In vitro Activity of Ceftaroline Against an International Collection of Kingella kingae Isolates Recovered From Carriers and Invasive Infections.

Joshua M Maher, Rodrigo E Mendes, Holly K Huynh

Pageof 1

Frequent Collaborators

3 joint publications

Rodrigo E Mendes

3 joint publications

John H Kimbrough

3 joint publications

Mariana Castanheira

1 joint publications

Holly K Huynh